ABOUT

Empowering pharmaceutical and biotech companies through value-added quality consulting and strategic partnership

Our Story

Cadoret Global was established on the premise that consultants are partners invested in the success of their clients.

We specialize in supporting start-up, virtual, early-stage, and small-size pharmaceutical and biotech companies in taking their investigational drug through development and into clinical trials.

Our aim is to provide high-caliber and phase-appropriate Quality and GxP Compliance consulting services tailored to our clients’ budget and timelines.

VALUE - INTEGRITY - PARTNERSHIP

Our Team

  • Enith Morillo

    CEO & Founder

  • Mark Morse

    Finance

  • Marlena Huerta

    Finance

  • Jill Santopietro Panall

    Human Resources

  • Sandy Tremblay

    Business Management

  • Ann Marie McCormick

    Executive Administration

  • Melanie Rodriguez

    Operations & Audits Management

Our guiding principles

  • We collaborate and communicate effectively with your organization and those you work with.

  • Our team understands and is ready to meet the variable and rushed demands of the development lifecycle.

  • At Cadoret Global, we know how to wear multiple hats and assist our Clients with prioritization of work.

  • Our niche is to give companies a hand in setting a foundation for success through procedures, processes and scalable, phase-appropriate systems.

  • We are willing to go the extra mile for your success. Every. Time.

  • We have proven experience in helping companies like yours lay the foundation for Quality and GxP Compliance from the get-go.

  • At Cadoret Global, we know deliverables and timelines impact the bottom line, and prioritize accordingly.

Our founder

Enith Morillo
Founder

Enith is a dependable and versatile Senior Quality Assurance professional and CGMP Auditor with almost two decades of experience in the FDA and DEA regulated pharmaceutical field.

She has a proven track record in supporting emerging, early stage, and virtual pharmaceuticals throughout the drug development lifecycle and into clinical trials. Enith is an adept collaborator with CMC and CMO teams, ensuring phase-appropriate, quality operations from starting materials to successful regulatory filings. She has extensive experience in guiding drugs from development through validation, PAI, and commercialization.

Enith's expertise includes CGMP auditing, both domestically and internationally, of API and DP manufacturers, contract laboratories, packagers, and distributors, among others. While her predominant experience lies in small molecule oral solid dosage forms, she has also worked with gene therapy and biopharmaceutical products.

She holds a Masters and Bachelors of Science in Electrical and Biomedical Engineering from Worcester Polytechnic Institute.

Outside of work, Enith enjoys traveling, writing, and mentoring others.

A Cadre of Experienced Consultants

Social Responsibility

Giving back to the community has been a priority for Cadoret Global from Day 1.

We take pride in sharing our knowledge of the industry and building stronger communities. Working in the pharmaceutical world, our goal is to improve lives. Besides the work we do on a daily basis, we engage in diverse activities to improve the world in any capacity we can.

  • "Overall, we are very impressed by the expertise, value, and partnership provided by Cadoret Global."

    “Cadoret Global has been the perfect QA partner for our company, a small pharma focusing on early-stage development. Enith and her team are very experienced in all aspects of CMC and Clinical Supply Chain. Cadoret helped us to establish our quality system, audited our global network of vendors, and oversaw numerous successful manufacturing campaigns. As a small company, we especially appreciate that Cadoret is always very responsive and resolved issues rapidly without compromising product quality. Cadoret also contributed significantly to the due diligence process that led to our successful acquisition by a big pharma company, who is completely satisfied with Cadoret’s work. Overall, we are very impressed by the expertise, value, and partnership provided by Cadoret Global.”

    TECHNICAL OPERATIONS - BIOTECH COMPANY

  • "You have managed to integrate all your expertise seamlessly and quickly into the greater company team. "

    "I cannot imagine a better way to start my foray into CMC and QA/QC than working with all of you [Cadoret Global team]. As you know, this was not (and still really isn’t) my expertise so I truly appreciate all your support, understanding and patience in explaining to me and the team what and why needs to be done when. I have full confidence in your ability to get business done on time and in the highest quality and in always keeping our success front-and-center in everything you do. You have managed to integrate all your expertise seamlessly and quickly into the greater company team. It is largely because of all your tireless contributions and your unwavering determination to succeed at solving difficult problems that our company is now able to plan on becoming a clinical company in early 2023.

    HEAD OF CMC - MEDICINAL CHEMISTRY CLINICAL COMPANY

  • "...integral part of the team"

    “Working with Enith and her team of experts at Cadoret Global has been such a pleasure. They understand how to build systems and processes that are phase-appropriate based on the stage of the company. They have been an integral part of the team in helping us manage through some key challenges successfully.”

    SENIOR VP DEVELOPMENT, OPERATIONS and REGULATORY AFFAIRS COMPANY

  • "... deep bench of drug development experts"

    “We all need to appreciate Enith's deep bench of drug development experts that she has assembled at Cadoret and has deployed promptly at our company on several occasions over the past year.”

    HEAD OF CMC - NEUROSCIENCE PHARMACEUTICAL COMPANY

  • "...patience and resilience "

    “During the last almost 3 years, Enith has been an integrated member of our team and her great support to all CMC activities, willingness to take late night/early morning calls and travel/respond to multiple emergencies, as well as patience and resilience as we were navigating through many challenges are very highly appreciated.”

    HEAD - PHARMACEUTICAL DEVELOPMENT PHARMACEUTICAL COMPANY